millennium Resources | BNET
On GameSpot: Wii Fit tells 10-year-old she's fat

Resources

129 Resources for

millennium

  • Subscribe to this listing via:
  • RSS
  • Email
Did you mean Millennium Pharmaceuticals Inc. (158 results)

BNET Industries

Millennium Pharmaceuticals Inc.
Millennium Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing medicines to improve the lives of patients with cancer, inflammatory bowel diseases and...
Millennium Pharmaceuticals Inc. company page on BNET »

BNET Resources

Millennium Hotels and Resorts selects Micros Systems of Columbia
Micros Systems Inc., of Columbia, a provider of information systems to the hospitality and retail industries, said it has been selected by Millennium Hotels and Resorts to upgrade property management and food and beverage point-of-sale systems. Millennium will install the systems in its 14 hotel properties in the United States....
Tags: Millennium
Research articles 2008-02-19
Millennium Hotels selects Maryland-based Micros Systems
Micros Systems Inc., of Columbia, a provider of information systems to the hospitality and retail industries, said it has been selected by Millennium Hotels and Resorts to upgrade property management and food and beverage point-of-sale systems. Millennium will install the systems in its 14 hotel properties in the United States....
Tags: Millennium
Research articles 2008-02-07
Sage Software Adds Integrated Payment Processing Capabilities, Advanced Data Examiner Functionality to Latest Version of Its Millennium Donor Relationship Management Software
Sage Software today announced the availability of Millennium , version 7.6, its Sage Fundraising solution for larger nonprofit organizations. Version 7.6 features a new, optional integration with Sage Software's Sage Payment Solutions to provide Millennium customers with a complete payment processing solution right from the software. ...
Tags: Millennium, payment, payment processing, Sage Software
Research articles 2007-06-04
Sales And Property Taxes At The Millennium
This presentation explains sales and property taxes at the millennium.
Tags: Sales Force Management, Free Trade, Taxes, Sales Strategy, Carnegie-Mellon University, Millennium, Sales, Financial Planning, Finance
Presentations 2007-09-16
Rock-Tenn Company Announces Millennium Paperboard Price Increases
NORCROSS, Ga. -- Rock-Tenn Company (NYSE:RKT) announced today a $40 per ton price increase on all Millennium grades including Millennium Board[R], uncoated Millennium Board[R], DuraFrame[R], DuraFreeze[R] and DuraTote[TM]. This increase will be effective with shipments on April 16, 2007.
Tags: Millennium
Research articles 2007-03-16
Fitch Assigns Millennium Partners a 'BBB' Counterparty Rating
NEW YORK -- Fitch Ratings assigns Millennium Partners, L.P. Millennium a long-term Issuer Default Rating IDR counterparty rating of 'BBB' and a short-term Issuer Rating of 'F2'. Founded in 1989 by Israel Englander, Millennium is a multi-strategy hedge fund with over 100 portfolio managers and approximately $8.4 billion in assets...
Tags: Fitch, Millennium
Research articles 2007-01-24
Ericsson and Columbia's Earth Institute join forces to empower Millennium Villages through communications
Ericsson (NASDAQ: ERIC), the world's leading telecommunications supplier, today announced it is partnering with The Earth Institute at Columbia University to provide connectivity to the Millennium Villages project. This partnership is designed to bring mobile communication and the Internet to approximately 400,000 people in 10 African countries where the project...
Tags: Ericsson Inc., Millennium
Research articles 2007-09-10
Millennium Hilton settles 9/11 claims.(News)(Millennium and Copthorne Hotels PLC)(CDL Hotels USA Inc.)(Brief article)
Byline: RUPAL PAREKH NEW YORK-CDL Hotels USA Inc., a subsidiary of London-based Millennium & Copthorne Hotels P.L.C., reached a final settlement with a St. Paul Travelers Cos. Inc. unit last week over alleged property damages and lost business Byline: RUPAL PAREKH ...
Tags: 9/11 commission, Hilton Hotels Corp., Millennium, Travelers Property Casualty Corp.
Research articles 2005-03-21
Ericsson partners with The Earth Institute in the Millennium Villages project
NORDIC BUSINESS REPORT-10 September 2007-Ericsson partners with The Earth Institute in the Millennium Villages projectC1994-2007 M2 COMMUNICATIONS LTD http://www.m2.com
Tags: Ericsson Inc., Millennium
Research articles 2007-09-10
REX Stores' Interest in Millennium Ethanol, LLC to Be Acquired by U.S. BioEnergy Corporation
DAYTON, Ohio -- REX Stores Corporation (NYSE: RSC) today announced that pursuant to the May 31, 2007 announcement by U.S. BioEnergy Corporation (NASDAQ: USBE) of its proposed acquisition of Millennium Ethanol, LLC, of Marion, South Dakota, REX has entered into an agreement with U.S. BioEnergy Corporation and Millennium Ethanol for...
Tags: Millennium
Research articles 2007-06-01
Willis, Millennium Hilton settle lawsuit over WTC property program; Broker agrees to pay $17.5 million in coverage dispute.(News)(Millennium & Copthorne Hotels P.L.C. cases with Willis Group Holdings Ltd)(Brief article)
Byline: RUPAL PAREKH NEW YORK-Millennium & Copthorne Hotels P.L.C. last week said it has reached a $17.5 million settlement with a unit of Willis Group Holdings Ltd. over the handling of its 2001 property program and losses from the Sept. 11 t Byline:...
Tags: Hilton Hotels Corp., Millennium
Research articles 2006-12-04
Millennium Initiates Phase II Clinical Trial With VELCADE and Rituximab in Patients With Indolent Non-Hodgkin's Lymphoma
In this article Millennium Pharmaceuticals, Inc. discusses the initiation of a multicenter phase II clinical trial of VELCADE Bortezomib for injection in combination with rituximab in patients with relapsed or refractory indolent follicular and marginal zone non-Hodgkin's lymphoma. The randomized study will assess efficacy, overall safety and tolerability of the...
Tags: Millennium Pharmaceuticals Inc., VELCADE, Patient, Millennium
White papers 2004-05-13
MCA leaders urged to reconsider takeover of dailies, BUSINESS TIMES
Business Times Malaysia 06-06-2001 IN today's world, e-business is increasingly defining the way business is done around the world. In fact, it is estimated that within the next three years, 60 per cent of Internet users will be outside the U...
Tags: Middlesex University, Millennium
Research articles 2001-06-06
Millennium Initiates Phase II Clinical Trial With MLN1202 in Patients With Rheumatoid Arthritis
In this article Millennium Pharmaceuticals, Inc. discusses the initiation of a multicenter phase II clinical trial of MLN1202 in approximately 30 patients with rheumatoid arthritis. MLN1202, a novel humanized monoclonal antibody, is specifically designed to block the MCP-1/CCR2 chemokine pathway, which is believed to play a central role in a...
Tags: Millennium, Millennium Pharmaceuticals Inc., Patient
White papers 2003-10-14
Millennium Initiates Phase I/II Clinical Trial of MLN2704 in Patients With Metastatic Androgen-Independent Prostate Cancer Second Clinical Trial With MLN2704
In this article Millennium Pharmaceuticals, Inc. discusses the initiation of a phase I/II multiple ascending-dose clinical trial of MLN2704 in patients with metastatic androgen-independent prostate cancer. MLN2704 is designed to deliver the maytansinoid chemotherapeutic agent, DM1, directly to prostate cancer cells through a targeted monoclonal antibody vehicle (T-MAV) that binds...
Tags: Millennium Pharmaceuticals Inc., Clinical Trial, Patient, Millennium, MLN2704, Healthcare
White papers 2003-10-09
Millennium Initiates Phase I/II Clinical Trial of MLN2704 in Patients With Metastatic Androgen-Independent Prostate Cancer
In this article Millennium Pharmaceuticals, Inc. discusses about the initiation of a phase I/II multiple ascending-dose clinical trial of MLN2704 in patients with metastatic androgen-independent prostate cancer. MLN2704 is designed to deliver the maytansinoid chemotherapeutic agent, DM1, directly to prostate cancer cells through a targeted monoclonal antibody vehicle (T-MAV) that...
Tags: Millennium, MLN2704, Millennium Pharmaceuticals Inc., Patient
White papers 2003-10-09
Cerner Announces Availability of Millennium 2007
KANSAS CITY, Mo. -- Cerner Corp. (NASDAQ:CERN) today announced the availability of Cerner Millennium[R] 2007, a healthcare information technology computing platform that helps health professionals improve safety, quality and efficiency. Combining technology with knowledge, the Cerner Millennium platform allows health professionals to run tests, make diagnoses, place orders, fill medications,...
Tags: Cerner Corp., Millennium
Research articles 2006-11-15
Millennium Announces Assignment of Medicare Code for Velcade (Bortezomib) for Injection
In this article Millennium Pharmaceuticals, Inc. informs that the Center for Medicare and Medicaid Services CMS has qualified VELCADE for pass-through status and assigned it to a Healthcare Common Procedure Coding System HCPCS whereby hospitals may obtain reimbursement for VELCADE under the hospital outpatient prospective payment system OPPS effective October...
Tags: Millennium, Millennium Pharmaceuticals Inc., Medicare, VELCADE
White papers 2003-09-26
Offshore Outsourcing: Survival Strategy Of The New Millennium?
A National Association of Software and Services India-McKinsey study, predicts the India offshore software and service sector will potentially be a $666B industry by year 2005. This begs the question, is outsourcing, let alone outsourcing to India, the survival strategy of the new millennium? This paper will address why more...
Tags: Millennium, Strategy, India, Offshore Outsourcing, Outsourcing, It Operations, Business Operations, Outsourcing & Subcontracting
White papers 2003-08-14
Millennium Announces Preliminary Phase I and Phase II Findings of VELCADE (Bortezomib) for Injection in Studies of Non-Hodgkin's Lymphoma and Solid Tumors
In this article Millennium Pharmaceuticals, Inc. discusses the results of several clinical trials with its novel oncology product VELCADE, in which early signs of anti-tumor activity were observed with VELCADE as both a single agent and in combination with other therapies. VELCADE Studied as a Single Agent in Non-Hodgkin's Lymphoma...
Tags: Millennium Pharmaceuticals Inc., VELCADE, Millennium
White papers 2003-06-02
advertisement
advertisement